Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. | Int J Mol Sci | 2023 | 37895120 | PubTator, text mining | PubMed |
| Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers. | Cancers (Basel) | 2023 | 37894324 | PubTator, text mining | PubMed |
| Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. | Cancer Cell | 2023 | 37890493 | PubTator, text mining | PubMed |
| Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience. | Cureus | 2023 | 37885525 | PubTator, text mining | PubMed |
| Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia. | BMC Cancer | 2023 | 37875840 | PubTator, text mining | PubMed |
| PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors. | Acta Neuropathol | 2023 | 37870637 | PubTator, text mining | PubMed |
| Composite Lymphoma's Ability to Adapt and Change Through Plasticity: A Case Report and Literature Review. | Cureus | 2023 | 37868530 | PubTator, text mining | PubMed |
| PD-L1 expression-related PI3K pathway correlates with immunotherapy efficacy in gastric cancer. | Ther Adv Med Oncol | 2023 | 37868079 | PubTator, text mining | PubMed |
| A Practical Approach to Small Round Cell Tumors Involving the Gastrointestinal Tract and Abdomen. | Surg Pathol Clin | 2023 | 37863565 | PubTator, text mining | PubMed |
| Evolution of clonal hematopoiesis. | Clin Transl Med | 2023 | 37846136 | PubTator, text mining | PubMed |
| Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia. | Cancer Drug Resist | 2023 | 37842232 | PubTator, text mining | PubMed |
| Soft tissue sarcoma with ZC3H7B::BCOR fusion in a male mimicking low-grade fibromyxoid sarcoma - A case report. | Pathol Res Pract | 2023 | 37837859 | PubTator, text mining | PubMed |
| Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong. | Cancers (Basel) | 2023 | 37835574 | PubTator, text mining | PubMed |
| SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes. | bioRxiv | 2023 | 37829615 | PubTator, text mining | PubMed |
| [Clinical and morphological characteristics of Ewing's sarcoma and the algorithm for diagnosing undifferentiated round cell sarcomas]. | Arkh Patol | 2023 | 37814845 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Analysis of 3 Uterine Adenosarcomas with Heterogeneously Differentiated Genomic Mutations. | Int J Anal Chem | 2023 | 37810911 | PubTator, text mining | PubMed |
| Nuclear mitochondria-related genes-based molecular classification and prognostic signature reveal immune landscape, somatic mutation, and prognosis for glioma. | Heliyon | 2023 | 37809472 | PubTator, text mining | PubMed |
| Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. | J Exp Clin Cancer Res | 2023 | 37803464 | PubTator, text mining | PubMed |
| European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia. | Leukemia | 2023 | 37794101 | PubTator, text mining | PubMed |
| Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study. | Leukemia | 2023 | 37794100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=20